Icure Pharmaceutical (XKRX:175250) Days Sales Outstanding : 47.54 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical Days Sales Outstanding?

Icure Pharmaceutical's average Accounts Receivable for the three months ended in Mar. 2024 was ₩8,303 Mil. Icure Pharmaceutical's Revenue for the three months ended in Mar. 2024 was ₩15,938 Mil. Hence, Icure Pharmaceutical's Days Sales Outstanding for the three months ended in Mar. 2024 was 47.54.

The historical rank and industry rank for Icure Pharmaceutical's Days Sales Outstanding or its related term are showing as below:

XKRX:175250' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.97 Med: 53.52 Max: 68.78
Current: 57.52

During the past 10 years, Icure Pharmaceutical's highest Days Sales Outstanding was 68.78. The lowest was 42.97. And the median was 53.52.

XKRX:175250's Days Sales Outstanding is ranked better than
63.86% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs XKRX:175250: 57.52

Icure Pharmaceutical's Days Sales Outstanding declined from Mar. 2023 (53.74) to Mar. 2024 (47.54).

Icure Pharmaceutical Days Sales Outstanding Historical Data

The historical data trend for Icure Pharmaceutical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical Days Sales Outstanding Chart

Icure Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

53.32

50.92

64.05

56.34

51.08

Icure Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															53.74	60.47	55.35	65.70	47.54

Competitive Comparison of Icure Pharmaceutical's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Icure Pharmaceutical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icure Pharmaceutical's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Icure Pharmaceutical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Icure Pharmaceutical's Days Sales Outstanding falls into.

Icure Pharmaceutical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Icure Pharmaceutical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (8174.29	+	7725.53)	/	2 )	/	56806.335	*	365
=	7949.91					/	56806.335	*	365
=	51.08

Icure Pharmaceutical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (7725.53	+	8880.009)	/	2 )	/	15937.952	*	365 / 4
=	8302.7695					/	15937.952	*	365 / 4
=	47.54

Icure Pharmaceutical (XKRX:175250) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Icure Pharmaceutical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Icure Pharmaceutical (XKRX:175250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR

Website

https://www.icure.co.kr

Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical (XKRX:175250) Headlines

No Headlines